Influence of Previous Corticosteroid Therapy on Temporal Artery Biopsy Yield in Giant Cell Arteritis

Seminars in Arthritis and Rheumatism

Volumn 37, Issue 1, 2007, Pages 13-19

  Narváez, Javier ^a   Bernad, Berta ^a   Roig Vilaseca, Daniel ^a   García Gómez, Carmen ^a   Gómez Vaquero, Carmen ^a   Juanola, Xavier ^a   Rodriguez Moreno, Jesús ^a   Nolla, Joan M ^a   Valverde, José ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

corticosteroid treatment; giant cell (temporal) arteritis; temporal artery biopsy yield

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ADULT; AGED; ARTICLE; BLOOD VESSEL BIOPSY; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; GIANT CELL ARTERITIS; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; TEMPORAL ARTERY; TREATMENT DURATION;

ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; BIOPSY; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TEMPORAL ARTERIES; TEMPORAL ARTERITIS; TIME FACTORS;

EID: 34447640192     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2006.12.005     Document Type: Article

References (36)

1. Weyand C.M., and Goronzy M.D. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 139 (2003) 505-515
2. Smetana G.W., and Shmerling R.H. Does this patient have temporal arteritis?. JAMA 287 (2002) 92-101
3. Hall S., and Hunder G.G. Is temporal artery biopsy prudent?. Mayo Clin Proc 59 (1984) 793-796
4. Fauchald P., Rygvold O., and Oystese B. Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings. Ann Intern Med 77 (1972) 845-852
5. Allsop C.J., and Gallagher P.J. Temporal artery biopsy in giant cell arteritis. A reappraisal. Am J Surg Pathol 5 (1981) 317-323
6. Bengtsson B.A., and Malmvall B.E. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica: incidences of different clinical presentations and eye complications. Arthritis Rheum 24 (1981) 899-904
7. Hall S., Persellin S., Lie J.T., O'Brien P.C., Kurland L.T., and Hunder G.G. The therapeutic impact of temporal artery biopsy. Lancet 2 (1983) 1217-1220
8. Hedges T.R., Gieger G.L., and Albert D.M. The clinical value of negative temporal artery biopsy specimens. Arch Ophthalmol 101 (1983) 1251-1254
9. Nadeau S.E. Temporal arteritis: a decision-analytic approach to temporal artery biopsy. Acta Neurol Scand 78 (1988) 90-100
10. Fernández-Herlihy L. Temporal arteritis: clinical aids to diagnosis. J Rheumatol 15 (1988) 1797-1801
11. Hunder G.G., Bloch D.A., Michel B.A., Stevens M.B., Arend W.P., Calabrese L.H., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33 (1990) 1122-1128
12. Chmelewski W.L., McKnight K.M., Agudelo C.A., and Wise C.M. Presenting features and outcomes in patients undergoing temporal artery biopsy. A review of 98 patients. Arch Intern Med 152 (1992) 1690-1695
13. Mason J.C., and Walport M.J. Giant cell arteritis. BMJ 305 (1992) 68-69
14. Gabriel S.E., O'Fallon W.M., Achkar A.A., Lie J.T., and Hunder G.G. The use of clinical characteristics to predict the results of temporal artery biopsy among patients with suspected giant cell arteritis. J Rheumatol 22 (1995) 93-96
15. Duhaut P., Pinède L., Bornet H., Demolombe-Ragué S., Dumontet C.H., Ninet J., et al. Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Ann Rheum Dis 58 (1999) 335-341
16. Bhatti M.T., and Tabendeh H. Giant cell arteritis: diagnosis and management. Curr Opin Ophthalmol 12 (2001) 1217-1220
17. González-Gay M.A. The diagnosis and management of patients with giant cell arteritis. J Rheumatol 32 (2005) 1186-1188
18. Taylor-Gjevre R., Vo M., Shukla D., and Resch L. Temporal artery biopsy for giant cell arteritis. J Rheumatol 32 (2005) 1279-1282
19. Klein R.G., Campbell R.J., Hunder G.G., and Carney J.A. Skip lesions in temporal arteritis. Mayo Clin Proc 51 (1976) 504-510
20. Poller D.N., Van Wyk Q., and Jeffrey M.J. The importance of skip lesions in temporal arteritis. J Clin Pathol 53 (2000) 137-139
21. Allison M.C., and Gallagher P.J. Temporal artery biopsy and corticosteroid treatment. Ann Rheum Dis 43 (1984) 416-417
22. Liozon F., Lavignac C., Emilie D., Liozon E., Crevon M.C., Vidal E., et al. Immunohistochemical study of lesions of temporal arteritis in Horton's disease. Ann Med Interne (Paris) 144 (1993) 85-91
23. Achkar A.A., Lie J.T., Hunder G.G., O′Fallon M., and Gabriel S.E. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis. Ann Intern Med 120 (1994) 987-992
24. Ray-Chaudhuri N., Kiné D., Tijani S.O., Parums D.V., Cartlidge N., Strong N.P., et al. Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol 86 (2002) 530-532
25. McDonnell P.J., Moore G.W., Miller N.R., Hutchins G.M., and Green W.R. Temporal arteritis: a clinicopathologic study. Ophthalmology 93 (1986) 518-530
26. Font R.L., and Prabhakaran V.C. Histologic parameters helpful to recognize steroid-treated temporal arteritis. An analysis of thirty-five cases. Br J Ophthalmol 20 (2006) [Epub ahead of print]
27. González-Gay M.A., García-Porrua C., Llorca J., González-Louzao C., and Rodriguez-Ledo P. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 30 (2001) 249-256
28. To K.W., Enzer Y.R., and Tsiaras W.G. Temporal artery biopsy after one month of corticosteroid therapy. [letter]. Am J Ophthalmol 117 (1994) 265-267
29. Guevara R.A., Newman N.J., and Grossniklaus H.E. Positive temporal artery biopsy 6 months after prednisone treatment. [letter]. Arch Ophthalmol 116 (1998) 1252-1253
30. Kopelman H. Temporal artery biopsy. [letter]. BMJ 297 (1988) 1470
31. Narváez J., Nolla-Solé J.M., Clavaguera M.T., Valverde-García J., and Roig-Escofet D. Temporal arteritis and polymyalgia rheumatica in north-eastern Spain: clinical spectrum and relationship over a 15 year period. Joint Bone Spine 70 (2003) 33-39
32. Narváez J., Nolla-Solé J.M., Clavaguera M.T., Valverde-García J., and Roig-Escofet D. Long-term therapy in polymyalgia rheumatica: effect of coexistent temporal arteritis. J Rheumatol 26 (1999) 1945-1952
33. Myklebust G., and Gran J.T. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 35 (1996) 1161-1168
34. Ayoub W.T., Franklin C.M., and Torreti D. Polymyalgia rheumatica. Duration of therapy and long-term outcome. Am J Med 79 (1985) 309-315
35. Jones J.G., and Hazleman B.L. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 40 (1981) 1-5
36. Kent III R.B., and Thomas L. Temporal artery biopsy. Am Surg 56 (1990) 16-21